These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24987766)

  • 1. Editorial comment.
    de Almeida JC
    Int Braz J Urol; 2014; 40(2):160. PubMed ID: 24987766
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Comment.
    Klotz L
    Urology; 2015 Nov; 86(5):996. PubMed ID: 26590040
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial Comment.
    Shah P; Moreira DM
    Urology; 2015 Nov; 86(5):995-6. PubMed ID: 26590039
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Dall'Era M
    J Urol; 2013 Jul; 190(1):96. PubMed ID: 23624151
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply.
    Reese AC; Carter HB
    Urology; 2015 Nov; 86(5):997. PubMed ID: 26590041
    [No Abstract]   [Full Text] [Related]  

  • 6. Active surveillance and radical prostatectomy.
    Bangma CH
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S355-6. PubMed ID: 21944013
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Adamy A
    J Urol; 2013 Oct; 190(4):1222-3. PubMed ID: 23856521
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment.
    Cary KC; Carroll PR
    J Urol; 2013 Oct; 190(4):1223. PubMed ID: 23856519
    [No Abstract]   [Full Text] [Related]  

  • 9. The ProtecT trial: what can we expect?
    Roobol MJ; Bokhorst LP
    Lancet Oncol; 2014 Sep; 15(10):1046-7. PubMed ID: 25163904
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting.
    Aus G
    Eur Urol; 2007 Oct; 52(4):1043. PubMed ID: 17933028
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials: ProtecT-ing against prostate cancer.
    Stone L
    Nat Rev Urol; 2014 Nov; 11(11):601. PubMed ID: 25201617
    [No Abstract]   [Full Text] [Related]  

  • 12. Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.
    van der Poel HG; van den Bergh RC
    Int Braz J Urol; 2016; 42(3):413-7. PubMed ID: 27286101
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial Comment to: SAMS: a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer.
    Djavan B
    Scand J Urol; 2013 Oct; 47(5):357. PubMed ID: 24102231
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial Comment to: SAMS: a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer.
    Rannikko A
    Scand J Urol; 2013 Oct; 47(5):356. PubMed ID: 24102230
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathological, oncologic and functional outcomes of radical prostatectomy following active surveillance.
    Satkunasivam R; Kulkarni GS; Zlotta AR; Kalnin R; Trachtenberg J; Fleshner NE; Hamilton RJ; Jewett MA; Finelli A
    J Urol; 2013 Jul; 190(1):91-5. PubMed ID: 23321581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment.
    Ellimoottil C; Gupta GN; Quek ML
    Urology; 2015 Feb; 85(2):441. PubMed ID: 25623716
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    Schlomm T
    J Urol; 2013 Aug; 190(2):520. PubMed ID: 23647912
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
    Simmons L; Ahmed HU; Moore C; Emberton M
    BJU Int; 2011 Jan; 107(2):338. PubMed ID: 21208369
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Abaza R
    J Urol; 2011 Aug; 186(2):516-7; author reply 517. PubMed ID: 21680000
    [No Abstract]   [Full Text] [Related]  

  • 20. 'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?
    Wang LL; Wallis CJ; Sathianathen N; Lawrentschuk N; Murphy DG; Nam R; Moon D
    BJU Int; 2017 Apr; 119(4):513-514. PubMed ID: 27930856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.